Evidence map›Paper›PMID 41647292›Full record

ArticleESMO real world data and digital oncology2024

DIGICORE, an international research consortium, is building infrastructure and skills to transform digital oncology research across Europe.

J Anderson

Abstract readEditorial
In one paragraph

Article in ESMO real world data and digital oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

J AndersonIQVIA UK, London.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•DIGICORE is a pan-European network with a novel approach to enabling precision onclogy research at scale.•DIGICORE is scaling up its activities across Europe, having been awarded a significant ERDF grant.•A funded training programme in OMOP research leadership is currently recruiting.•There are also opportunities to get involved in proof-of-concept OMOP studies.

Identifiers

PMID41647292
PMCPMC12836738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.